Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Alora launched in U.S.

May 22, 1997

Merck updates development of higher dose Zocor

May 21, 1997

Positive phase II/III results for Cortecs' Macritonin

May 20, 1997

FDA advisory committee recommends Roche's Xenical for weight loss

May 15, 1997

FDA approves Columbia's Crinone

May 15, 1997

GH secretagogues disclosed by Merck & Co.

May 14, 1997

Osiris Therapeutics obtains U.S. patent for mesenchymal stem cell gene therapy

May 13, 1997

Osaterone enhances bone formation in ovariectomized rats

May 12, 1997

Effects of L-692429 in obese and nonobese young men

May 12, 1997

Procter & Gamble and Hoechst Marion Roussel to comarket Actonel

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...